A UK-based leading clinical trials unit involves patients and members of the public across all areas of its work and is keen to learn how they can do better.
Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases
Cancer outcomes could improve if we learn lessons from pandemic to accelerate translation of research into practice
Patients at Great Ormond Street Hospital and Southampton Children's Hospital are taking part in research to work out how they respond to COVID-19 vaccination.
A proof-of-concept trial has identified a drug that may offer benefit some patients hospitalised with COVID-19 pneumonia.
A new clinical trial has launched in the UK to determine whether a third vaccine will improve the immune response of people who have weakened immune systems.
A significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions mount a low or undetectable immune response after two doses of the same COVID-19 vaccine
The University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
A new clinical trial being sponsored by the University of Birmingham has opened for recruitment aiming to investigate the efficacy of a novel treatment for patients affected by a specific type of blood cancer.
Birmingham Precision Medicine Centre Industry Trials Hub is changing the relationship between the University of Birmingham and its industry partners.